In a world where medical breakthroughs are increasingly vital to combat complex diseases, a remarkable discovery by researchers from the University of Utah and Sethera Therapeutics has captured the attention of the biotech community with a novel enzyme known as PapB. This advancement promises to
What if the secret to conquering one of humanity’s deadliest foes lies hidden in the microscopic world of bacterial cells? Tuberculosis (TB), claiming millions of lives each year, continues to defy modern medicine with its grueling treatment demands and rising drug resistance. Yet, a revolutionary
Imagine a landscape in biopharmaceutical research where the journey from concept to cure is no longer a decade-long slog but a streamlined sprint, driven by technology that predicts outcomes with startling accuracy. This vision is becoming reality with the launch of BiortusAI, an innovative
The realm of hemophilia treatment is witnessing a transformative wave, with innovative therapies challenging the status quo of managing this genetic blood clotting disorder, which has burdened patients for decades with frequent infusions to replace missing clotting factors. Now, a newly approved
We’re sitting down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology within the industry. With a career dedicated to pushing the boundaries of innovation, Ivan offers a unique perspective on how science and tech intersect
Drug discovery has long been a daunting endeavor, with the staggering statistic that developing a single new drug can cost upwards of $1 billion and take over a decade to reach the market. Imagine a world where this timeline is slashed, costs are dramatically reduced, and even smaller research
